39344343|t|Danggui Shaoyao San Alleviates Early Cognitive Impairment in Alzheimer's Disease Mice Through IRS1/GSK3beta/Wnt3a-beta-Catenin Pathway.
39344343|a|INTRODUCTION: Alzheimer's disease (AD) is a neurodegenerative disease characterized by Amyloid plaques and neurofibrillary tangles. We explored the potential mechanism by which Danggui Shaoyao San (DSS) modulates central glucose metabolism via the insulin receptor substrate 1 (IRS1)/glycogen synthase kinase-3beta (GSK3beta)/Wnt3a-beta-catenin pathway, thereby exerting protective effects on cognitive functions. METHODS: In vitro, HT22 cells were induced with streptozotocin (STZ) to investigate the impact of GSK3beta on pathway transduction. The active components in the DSS stock solution were validated using mass spectrometry. Subsequently, an AD model in C57BL/6J mice was established through STZ injection into both ventricles. The success of the model was validated behaviorally and pathologically. The Morris Water Maze (MWM) test, immunohistochemistry, Western blotting, quantitative reverse transcription-PCR, and 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) were employed to evaluate the influence of DSS on memory and pathological changes in AD. RESULTS: The DSS stock solution, rich in active components, ameliorated the memory deficits in AD mice in the MWM. In vitro, GSK3beta exhibited regulatory control over Wnt and beta-catenin, with GSK3beta inhibition mitigating beta-amyloid and tau redundancies at protein and gene levels, facilitating signal transduction. In vivo, DSS impacted key targets in the IRS1/GSK3beta/Wnt3a-beta-catenin pathway, mitigated senile plaques resulting from amyloid beta (Abeta) deposition and neurofiber tangles induced by tau hyperphosphorylation, and alleviated the decline in central glucose metabolism observed in FDG-PET. CONCLUSIONS: Our findings suggest that DSS potentially confers cognitive protection by alleviating central hypoglycemia through the IRS1/GSK3beta/Wnt3a-beta-catenin pathway. This may serve as a promising therapeutic avenue for AD.
39344343	37	57	Cognitive Impairment	Disease	MESH:D003072
39344343	61	80	Alzheimer's Disease	Disease	MESH:D000544
39344343	81	85	Mice	Species	10090
39344343	94	98	IRS1	Gene	16367
39344343	99	107	GSK3beta	Gene	56637
39344343	108	113	Wnt3a	Gene	22416
39344343	114	126	beta-Catenin	Gene	12387
39344343	150	169	Alzheimer's disease	Disease	MESH:D000544
39344343	171	173	AD	Disease	MESH:D000544
39344343	180	205	neurodegenerative disease	Disease	MESH:D019636
39344343	223	238	Amyloid plaques	Disease	MESH:D058225
39344343	243	266	neurofibrillary tangles	Disease	MESH:D055956
39344343	357	364	glucose	Chemical	MESH:D005947
39344343	384	412	insulin receptor substrate 1	Gene	16367
39344343	414	418	IRS1	Gene	16367
39344343	420	450	glycogen synthase kinase-3beta	Gene	56637
39344343	452	460	GSK3beta	Gene	56637
39344343	462	467	Wnt3a	Gene	22416
39344343	468	480	beta-catenin	Gene	12387
39344343	569	573	HT22	CellLine	CVCL:0321
39344343	598	612	streptozotocin	Chemical	MESH:D013311
39344343	614	617	STZ	Chemical	MESH:D013311
39344343	648	656	GSK3beta	Gene	56637
39344343	787	789	AD	Disease	MESH:D000544
39344343	799	807	C57BL/6J	CellLine	CVCL:C0MW
39344343	808	812	mice	Species	10090
39344343	837	840	STZ	Chemical	MESH:D013311
39344343	1063	1085	18F-fluorodeoxyglucose	Chemical	MESH:D019788
39344343	1116	1119	FDG	Chemical	MESH:D019788
39344343	1210	1212	AD	Disease	MESH:D000544
39344343	1290	1305	memory deficits	Disease	MESH:D008569
39344343	1309	1311	AD	Disease	MESH:D000544
39344343	1312	1316	mice	Species	10090
39344343	1339	1347	GSK3beta	Gene	56637
39344343	1390	1402	beta-catenin	Gene	12387
39344343	1409	1417	GSK3beta	Gene	56637
39344343	1577	1581	IRS1	Gene	16367
39344343	1582	1590	GSK3beta	Gene	56637
39344343	1591	1596	Wnt3a	Gene	22416
39344343	1597	1609	beta-catenin	Gene	12387
39344343	1636	1643	plaques	Disease	MESH:D003773
39344343	1673	1678	Abeta	Gene	11820
39344343	1695	1713	neurofiber tangles	Disease	MESH:D055956
39344343	1789	1796	glucose	Chemical	MESH:D005947
39344343	1820	1823	FDG	Chemical	MESH:D019788
39344343	1936	1948	hypoglycemia	Disease	MESH:D007003
39344343	1961	1965	IRS1	Gene	16367
39344343	1966	1974	GSK3beta	Gene	56637
39344343	1975	1980	Wnt3a	Gene	22416
39344343	1981	1993	beta-catenin	Gene	12387
39344343	2056	2058	AD	Disease	MESH:D000544
39344343	Association	MESH:D007003	22416
39344343	Association	MESH:D007003	56637
39344343	Association	MESH:D005947	16367
39344343	Association	MESH:D000544	56637
39344343	Association	MESH:D003072	56637
39344343	Association	12387	56637
39344343	Association	12387	22416
39344343	Association	MESH:D005947	MESH:D019788
39344343	Association	12387	16367
39344343	Association	MESH:D007003	16367
39344343	Association	MESH:D007003	12387
39344343	Association	MESH:D005947	56637

